Geoffrey A. Heinzl

ORCID: 0000-0001-5291-5999
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Hemoglobin structure and function
  • Heme Oxygenase-1 and Carbon Monoxide
  • Synthesis and biological activity
  • Synthesis and Biological Evaluation
  • Quinazolinone synthesis and applications
  • Synthesis and Characterization of Heterocyclic Compounds
  • Microbial Natural Products and Biosynthesis
  • Neonatal Health and Biochemistry
  • Cannabis and Cannabinoid Research
  • Enzyme Catalysis and Immobilization
  • Antibiotic Resistance in Bacteria
  • Cytokine Signaling Pathways and Interactions
  • Bacterial Genetics and Biotechnology
  • Viral Infectious Diseases and Gene Expression in Insects
  • Synthesis of heterocyclic compounds
  • Protein purification and stability
  • Melanoma and MAPK Pathways
  • Infectious Encephalopathies and Encephalitis
  • Catalytic C–H Functionalization Methods
  • Computational Drug Discovery Methods

Center for Drug Evaluation and Research
2018-2019

University of Maryland, Baltimore
2013-2018

New therapeutic targets are required to combat multidrug resistant infections, such as the iron-regulated heme oxygenase (HemO) of Pseudomonas aeruginosa, due links between iron and virulence dependence on an source during infection. Herein we report synthesis activity a series iminoguanidine-based inhibitors HemO. Compound 23 showed binding affinity 5.7 μM MIC50 52.3 μg/mL against P. aeruginosa PAO1. An in cellulo assay was developed by coupling HemO biliverdin-IXα-dependent infrared...

10.1021/acs.jmedchem.6b00757 article EN Journal of Medicinal Chemistry 2016-06-29

We herein report on the pharmacophore determination of ERK docking domain inhibitor (Z)-3-(2-aminoethyl)-5-(4-ethoxybenzylidene)thiazolidine-2,4-dione, which has led to discovery compounds with greater selectivities for inhibiting proliferation melanoma cells containing active signaling.

10.1039/c3ob40199e article EN Organic & Biomolecular Chemistry 2013-01-01

Bacteria require iron for survival and virulence employ several mechanisms including utilization of the host heme containing proteins. The final step in releasing is oxidative cleavage by HemO. A recent computer aided drug design (CADD) study identified inhibitors bacterial HemOs. Herein we report near complete HN, N, CO, Cα, Cβ chemical shift assignment P. aeruginosa HemO absence presence (E)-3-(4-(phenylamino)phenylcarbamoyl)acrylic acid (3) (E)-N′-(4-(dimethylamino)benzylidene)...

10.1021/jm301819k article EN Journal of Medicinal Chemistry 2013-02-04

Abstract Base‐mediated cyclocondensation of chalcones and triazol‐3‐amines produces triazolopyrimidines.

10.1002/chin.201525205 article EN ChemInform 2015-06-01
Coming Soon ...